Microdosing psychedelics has received growing attention in recent years, as it’s been said to enhance creativity, increase focus, and lift the weight of depression. Now, scientists want to figure out whether using small amounts of these substances lives up to the hype. On Sept. 3, researchers from the Beckley Foundation and Imperial College of London launched a first-of-its-kind study to investigate the potential benefits of microdosing LSD. If the study goes well, it could provide powerful insights into the realm of diverse psychedelic-use.
Innovative Microdosing Research
The aim of the study, known as the “self-blinding microdose study,” is relatively straightforward: scientists want to know whether or not microdosing psychedelics produces verifiable, positive results in users.
When a person microdoses with psychedelics, they generally take a tiny dose of LSD or mushrooms. The concept is that these tiny doses are too small to produce a full-blown, out-of-body psychedelic experience, but large enough to activate and energize the brain. Many microdosers claim the practice improves their day-to-day lives and has a positive impact on workflow.
The scientists on this project are, thus, looking to see if people who report positive effects from microdosing are actually experiencing benefits from the drugs or if they’re